Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 332 entries
Sorted by: Best Match Show Resources per page
Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma.

Journal of gastrointestinal oncology

Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V.
PMID: 31602330
J Gastrointest Oncol. 2019 Oct;10(5):918-927. doi: 10.21037/jgo.2019.07.02.

BACKGROUND: Response of pancreatic adenocarcinoma to neoadjuvant chemotherapy (nCT) or chemoradiotherapy (nCRT) may be associated with prognosis, but long-term outcomes based on response to neoadjuvant therapy have not been well evaluated to date.METHODS: The National Cancer Database was queried...

Cite
Khattab A, Patruni S, Abel S, et al. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. J Gastrointest Oncol. 2019;10(5):918-927doi: 10.21037/jgo.2019.07.02.
Khattab, A., Patruni, S., Abel, S., Hasan, S., Ludmir, E. B., Finley, G., Monga, D., Wegner, R. E., & Verma, V. (2019). Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. Journal of gastrointestinal oncology, 10(5), 918-927. https://doi.org/10.21037/jgo.2019.07.02
Khattab, Ahmed, et al. "Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma." Journal of gastrointestinal oncology vol. 10,5 (2019): 918-927. doi: https://doi.org/10.21037/jgo.2019.07.02
Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. J Gastrointest Oncol. 2019 Oct;10(5):918-927. doi: 10.21037/jgo.2019.07.02. PMID: 31602330; PMCID: PMC6776797.
Copy Download .nbib Format: NLM
Time to Face Language: Embodied Mechanisms Underpin the Inception of Face-Related Meanings in the Human Brain.

Cerebral cortex (New York, N.Y. : 1991)

García AM, Hesse E, Birba A, Adolfi F, Mikulan E, Caro MM, Petroni A, Bekinschtein TA, Del Carmen García M, Silva W, Ciraolo C, Vaucheret E, Sedeño L, Ibáñez A.
PMID: 32577713
Cereb Cortex. 2020 Oct 01;30(11):6051-6068. doi: 10.1093/cercor/bhaa178.

In construing meaning, the brain recruits multimodal (conceptual) systems and embodied (modality-specific) mechanisms. Yet, no consensus exists on how crucial the latter are for the inception of semantic distinctions. To address this issue, we combined electroencephalographic (EEG) and intracranial...

Cite
García AM, Hesse E, Birba A, et al. Time to Face Language: Embodied Mechanisms Underpin the Inception of Face-Related Meanings in the Human Brain. Cereb Cortex. 2020;30(11):6051-6068doi: 10.1093/cercor/bhaa178.
García, A. M., Hesse, E., Birba, A., Adolfi, F., Mikulan, E., Caro, M. M., Petroni, A., Bekinschtein, T. A., Del Carmen García, M., Silva, W., Ciraolo, C., Vaucheret, E., Sedeño, L., & Ibáñez, A. (2020). Time to Face Language: Embodied Mechanisms Underpin the Inception of Face-Related Meanings in the Human Brain. Cerebral cortex (New York, N.Y. : 1991), 30(11), 6051-6068. https://doi.org/10.1093/cercor/bhaa178
García, Adolfo M, et al. "Time to Face Language: Embodied Mechanisms Underpin the Inception of Face-Related Meanings in the Human Brain." Cerebral cortex (New York, N.Y. : 1991) vol. 30,11 (2020): 6051-6068. doi: https://doi.org/10.1093/cercor/bhaa178
García AM, Hesse E, Birba A, Adolfi F, Mikulan E, Caro MM, Petroni A, Bekinschtein TA, Del Carmen García M, Silva W, Ciraolo C, Vaucheret E, Sedeño L, Ibáñez A. Time to Face Language: Embodied Mechanisms Underpin the Inception of Face-Related Meanings in the Human Brain. Cereb Cortex. 2020 Oct 01;30(11):6051-6068. doi: 10.1093/cercor/bhaa178. PMID: 32577713; PMCID: PMC7673477.
Copy Download .nbib Format: NLM
Molecular Response to Nanopatterned Implants in the Human Jaw Bone.

ACS biomaterials science & engineering

Karazisis D, Omar O, Petronis S, Thomsen P, Rasmusson L.
PMID: 34851620
ACS Biomater Sci Eng. 2021 Dec 01; doi: 10.1021/acsbiomaterials.1c00861. Epub 2021 Dec 01.

Implant surface modification by nanopatterning is an interesting route for enhancing osseointegration in humans. Herein, the molecular response to an intentional, controlled nanotopography pattern superimposed on screw-shaped titanium implants is investigated in human bone. When clinical implants are installed,...

Cite
Karazisis D, Omar O, Petronis S, et al. Molecular Response to Nanopatterned Implants in the Human Jaw Bone. ACS Biomater Sci Eng. 2021;doi: 10.1021/acsbiomaterials.1c00861.
Karazisis, D., Omar, O., Petronis, S., Thomsen, P., & Rasmusson, L. (2021). Molecular Response to Nanopatterned Implants in the Human Jaw Bone. ACS biomaterials science & engineering, . https://doi.org/10.1021/acsbiomaterials.1c00861
Karazisis, Dimitrios, et al. "Molecular Response to Nanopatterned Implants in the Human Jaw Bone." ACS biomaterials science & engineering vol. (2021). doi: https://doi.org/10.1021/acsbiomaterials.1c00861
Karazisis D, Omar O, Petronis S, Thomsen P, Rasmusson L. Molecular Response to Nanopatterned Implants in the Human Jaw Bone. ACS Biomater Sci Eng. 2021 Dec 01; doi: 10.1021/acsbiomaterials.1c00861. Epub 2021 Dec 01. PMID: 34851620.
Copy Download .nbib Format: NLM
The Obligate Symbiont ".

Frontiers in microbiology

Pasqualetti C, Szokoli F, Rindi L, Petroni G, Schrallhammer M.
PMID: 32733401
Front Microbiol. 2020 Jul 08;11:1425. doi: 10.3389/fmicb.2020.01425. eCollection 2020.

"

Cite
Pasqualetti C, Szokoli F, Rindi L, et al. The Obligate Symbiont ". Front Microbiol. 2020;11:1425doi: 10.3389/fmicb.2020.01425.
Pasqualetti, C., Szokoli, F., Rindi, L., Petroni, G., & Schrallhammer, M. (2020). The Obligate Symbiont ". Frontiers in microbiology, 111425. https://doi.org/10.3389/fmicb.2020.01425
Pasqualetti, Chiara, et al. "The Obligate Symbiont "." Frontiers in microbiology vol. 11 (2020): 1425. doi: https://doi.org/10.3389/fmicb.2020.01425
Pasqualetti C, Szokoli F, Rindi L, Petroni G, Schrallhammer M. The Obligate Symbiont ". Front Microbiol. 2020 Jul 08;11:1425. doi: 10.3389/fmicb.2020.01425. eCollection 2020. PMID: 32733401; PMCID: PMC7360802.
Copy Download .nbib Format: NLM
Dietary intake of cyanidin-3-glucoside induces a long-lasting cardioprotection from ischemia/reperfusion injury by altering the microbiota.

The Journal of nutritional biochemistry

Trinei M, Carpi A, Menabo' R, Storto M, Fornari M, Marinelli A, Minardi S, Riboni M, Casciaro F, DiLisa F, Petroni K, Tonelli C, Giorgio M.
PMID: 34864150
J Nutr Biochem. 2021 Dec 03;101:108921. doi: 10.1016/j.jnutbio.2021.108921. Epub 2021 Dec 03.

The anthocyanin class of flavonoids, including cyanidin-3-glucoside (C3G) present in berries, blood oranges and pigmented cereal crops, are food bioactives with antioxidant and anti-inflammatory action, capable to reduce myocardial ischemia/reperfusion (I/R) injury by unclear mechanism. Assessing the value of...

Cite
Trinei M, Carpi A, Menabo' R, et al. Dietary intake of cyanidin-3-glucoside induces a long-lasting cardioprotection from ischemia/reperfusion injury by altering the microbiota. J Nutr Biochem. 2021;101:108921doi: 10.1016/j.jnutbio.2021.108921.
Trinei, M., Carpi, A., Menabo', R., Storto, M., Fornari, M., Marinelli, A., Minardi, S., Riboni, M., Casciaro, F., DiLisa, F., Petroni, K., Tonelli, C., & Giorgio, M. (2021). Dietary intake of cyanidin-3-glucoside induces a long-lasting cardioprotection from ischemia/reperfusion injury by altering the microbiota. The Journal of nutritional biochemistry, 101108921. https://doi.org/10.1016/j.jnutbio.2021.108921
Trinei, Mirella, et al. "Dietary intake of cyanidin-3-glucoside induces a long-lasting cardioprotection from ischemia/reperfusion injury by altering the microbiota." The Journal of nutritional biochemistry vol. 101 (2021): 108921. doi: https://doi.org/10.1016/j.jnutbio.2021.108921
Trinei M, Carpi A, Menabo' R, Storto M, Fornari M, Marinelli A, Minardi S, Riboni M, Casciaro F, DiLisa F, Petroni K, Tonelli C, Giorgio M. Dietary intake of cyanidin-3-glucoside induces a long-lasting cardioprotection from ischemia/reperfusion injury by altering the microbiota. J Nutr Biochem. 2021 Dec 03;101:108921. doi: 10.1016/j.jnutbio.2021.108921. Epub 2021 Dec 03. PMID: 34864150.
Copy Download .nbib Format: NLM
An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia.

Muscle & nerve

Gemelli C, Traverso M, Trevisan L, Fabbri S, Scarsi E, Carlini B, Prada V, Mongini T, Ruggiero L, Patrone S, Gallone S, Iodice R, Pisciotta L, Zara F, Origone P, Rota E, Minetti C, Bruno C, Schenone A, Mandich P, Fiorillo C, Grandis M.
PMID: 34687219
Muscle Nerve. 2022 Jan;65(1):96-104. doi: 10.1002/mus.27448. Epub 2021 Nov 08.

INTRODUCTION/AIMS: Currently, there are no straightforward guidelines for the clinical and diagnostic management of hyperCKemia, a frequent and nonspecific presentation in muscle diseases. Therefore, we aimed to describe our diagnostic workflow for evaluating patients with this condition.METHODS: We selected...

Cite
Gemelli C, Traverso M, Trevisan L, et al. An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia. Muscle Nerve. 2021;65(1):96-104doi: 10.1002/mus.27448.
Gemelli, C., Traverso, M., Trevisan, L., Fabbri, S., Scarsi, E., Carlini, B., Prada, V., Mongini, T., Ruggiero, L., Patrone, S., Gallone, S., Iodice, R., Pisciotta, L., Zara, F., Origone, P., Rota, E., Minetti, C., Bruno, C., Schenone, A., Mandich, P., Fiorillo, C., & Grandis, M. (2022). An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia. Muscle & nerve, 65(1), 96-104. https://doi.org/10.1002/mus.27448
Gemelli, Chiara, et al. "An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia." Muscle & nerve vol. 65,1 (2022): 96-104. doi: https://doi.org/10.1002/mus.27448
Gemelli C, Traverso M, Trevisan L, Fabbri S, Scarsi E, Carlini B, Prada V, Mongini T, Ruggiero L, Patrone S, Gallone S, Iodice R, Pisciotta L, Zara F, Origone P, Rota E, Minetti C, Bruno C, Schenone A, Mandich P, Fiorillo C, Grandis M. An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia. Muscle Nerve. 2022 Jan;65(1):96-104. doi: 10.1002/mus.27448. Epub 2021 Nov 08. PMID: 34687219.
Copy Download .nbib Format: NLM
Dynamic expression of homeostatic ion channels in differentiated cortical astrocytes in vitro.

Pflugers Archiv : European journal of physiology

Formaggio F, Fazzina M, Estévez R, Caprini M, Ferroni S.
PMID: 34734327
Pflugers Arch. 2021 Nov 04; doi: 10.1007/s00424-021-02627-x. Epub 2021 Nov 04.

The capacity of astrocytes to adapt their biochemical and functional features upon physiological and pathological stimuli is a fundamental property at the basis of their ability to regulate the homeostasis of the central nervous system (CNS). It is well...

Cite
Formaggio F, Fazzina M, Estévez R, et al. Dynamic expression of homeostatic ion channels in differentiated cortical astrocytes in vitro. Pflugers Arch. 2021;doi: 10.1007/s00424-021-02627-x.
Formaggio, F., Fazzina, M., Estévez, R., Caprini, M., & Ferroni, S. (2021). Dynamic expression of homeostatic ion channels in differentiated cortical astrocytes in vitro. Pflugers Archiv : European journal of physiology, . https://doi.org/10.1007/s00424-021-02627-x
Formaggio, Francesco, et al. "Dynamic expression of homeostatic ion channels in differentiated cortical astrocytes in vitro." Pflugers Archiv : European journal of physiology vol. (2021). doi: https://doi.org/10.1007/s00424-021-02627-x
Formaggio F, Fazzina M, Estévez R, Caprini M, Ferroni S. Dynamic expression of homeostatic ion channels in differentiated cortical astrocytes in vitro. Pflugers Arch. 2021 Nov 04; doi: 10.1007/s00424-021-02627-x. Epub 2021 Nov 04. PMID: 34734327.
Copy Download .nbib Format: NLM
Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.

Biomedical materials (Bristol, England)

Svanström A, Rosendahl J, Salerno S, Leiva MC, Gregersson P, Berglin M, Bogestål Y, Lausmaa J, Oko A, Chinga-Carrasco G, Petronis S, Standoft S, Ståhlberg A, Håkansson J, Landberg G.
PMID: 34030145
Biomed Mater. 2021 Jun 25;16(4). doi: 10.1088/1748-605X/ac0451.

The cancer microenvironment influences tumor progression and metastasis and is pivotal to consider when designing

Cite
Svanström A, Rosendahl J, Salerno S, et al. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery. Biomed Mater. 2021;16(4)doi: 10.1088/1748-605X/ac0451.
Svanström, A., Rosendahl, J., Salerno, S., Leiva, M. C., Gregersson, P., Berglin, M., Bogestål, Y., Lausmaa, J., Oko, A., Chinga-Carrasco, G., Petronis, S., Standoft, S., Ståhlberg, A., Håkansson, J., & Landberg, G. (2021). Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery. Biomedical materials (Bristol, England), 16(4), . https://doi.org/10.1088/1748-605X/ac0451
Svanström, Andreas, et al. "Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery." Biomedical materials (Bristol, England) vol. 16,4 (2021). doi: https://doi.org/10.1088/1748-605X/ac0451
Svanström A, Rosendahl J, Salerno S, Leiva MC, Gregersson P, Berglin M, Bogestål Y, Lausmaa J, Oko A, Chinga-Carrasco G, Petronis S, Standoft S, Ståhlberg A, Håkansson J, Landberg G. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery. Biomed Mater. 2021 Jun 25;16(4). doi: 10.1088/1748-605X/ac0451. PMID: 34030145.
Copy Download .nbib Format: NLM
Corrigendum: Overview of Control Programs for Twenty-Four Infectious Cattle Diseases in Italy.

Frontiers in veterinary science

Tamba M, Pallante I, Petrini S, Feliziani F, Iscaro C, Arrigoni N, Di Sabatino D, Barberio A, Cibin V, Santi A, Ianniello M, Ruocco L, Pozzato N.
PMID: 34950728
Front Vet Sci. 2021 Dec 07;8:818480. doi: 10.3389/fvets.2021.818480. eCollection 2021.

[This corrects the article DOI: 10.3389/fvets.2021.665607.].

Cite
Tamba M, Pallante I, Petrini S, et al. Corrigendum: Overview of Control Programs for Twenty-Four Infectious Cattle Diseases in Italy. Front Vet Sci. 2021;8:818480doi: 10.3389/fvets.2021.818480.
Tamba, M., Pallante, I., Petrini, S., Feliziani, F., Iscaro, C., Arrigoni, N., Di Sabatino, D., Barberio, A., Cibin, V., Santi, A., Ianniello, M., Ruocco, L., & Pozzato, N. (2021). Corrigendum: Overview of Control Programs for Twenty-Four Infectious Cattle Diseases in Italy. Frontiers in veterinary science, 8818480. https://doi.org/10.3389/fvets.2021.818480
Tamba, Marco, et al. "Corrigendum: Overview of Control Programs for Twenty-Four Infectious Cattle Diseases in Italy." Frontiers in veterinary science vol. 8 (2021): 818480. doi: https://doi.org/10.3389/fvets.2021.818480
Tamba M, Pallante I, Petrini S, Feliziani F, Iscaro C, Arrigoni N, Di Sabatino D, Barberio A, Cibin V, Santi A, Ianniello M, Ruocco L, Pozzato N. Corrigendum: Overview of Control Programs for Twenty-Four Infectious Cattle Diseases in Italy. Front Vet Sci. 2021 Dec 07;8:818480. doi: 10.3389/fvets.2021.818480. eCollection 2021. PMID: 34950728; PMCID: PMC8691130.
Copy Download .nbib Format: NLM
Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate.

Journal of pediatric ophthalmology and strabismus

Petroni S, Catena G, Iarossi G, Federici M, Zinzanella G, Parrilla R, Valente P, Buzzonetti L.
PMID: 34928773
J Pediatr Ophthalmol Strabismus. 2021 Dec 20;1-5. doi: 10.3928/01913913-20211110-02. Epub 2021 Dec 20.

PURPOSE: To investigate the efficacy of combination therapy with laser photocoagulation, intravitreal ranibizumab, and sub-Tenon methylprednisolone acetate in patients presenting with advanced Coats' disease.METHODS: This was a retrospective analysis of 16 patients who underwent laser photocoagulation combined with intravitreal...

Cite
Petroni S, Catena G, Iarossi G, et al. Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate. J Pediatr Ophthalmol Strabismus. 2021;1-5doi: 10.3928/01913913-20211110-02.
Petroni, S., Catena, G., Iarossi, G., Federici, M., Zinzanella, G., Parrilla, R., Valente, P., & Buzzonetti, L. (2021). Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate. Journal of pediatric ophthalmology and strabismus, 1-5. https://doi.org/10.3928/01913913-20211110-02
Petroni, Sergio, et al. "Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate." Journal of pediatric ophthalmology and strabismus vol. (2021): 1-5. doi: https://doi.org/10.3928/01913913-20211110-02
Petroni S, Catena G, Iarossi G, Federici M, Zinzanella G, Parrilla R, Valente P, Buzzonetti L. Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate. J Pediatr Ophthalmol Strabismus. 2021 Dec 20;1-5. doi: 10.3928/01913913-20211110-02. Epub 2021 Dec 20. PMID: 34928773.
Copy Download .nbib Format: NLM
Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency.

Disease models & mechanisms

Niceforo A, Marioli C, Colasuonno F, Petrini S, Massey K, Tartaglia M, Bertini E, Moreno S, Compagnucci C.
PMID: 33468503
Dis Model Mech. 2021 Jan 19; doi: 10.1242/dmm.046391. Epub 2021 Jan 19.

The cytoskeletal network plays a crucial role in differentiation, morphogenesis, function and homeostasis of the nervous tissue, so that alterations in any of its components may lead to neurodegenerative diseases. Riboflavin transporter deficiency (RTD), a childhood-onset disorder characterized by...

Cite
Niceforo A, Marioli C, Colasuonno F, et al. Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency. Dis Model Mech. 2021;doi: 10.1242/dmm.046391.
Niceforo, A., Marioli, C., Colasuonno, F., Petrini, S., Massey, K., Tartaglia, M., Bertini, E., Moreno, S., & Compagnucci, C. (2021). Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency. Disease models & mechanisms, . https://doi.org/10.1242/dmm.046391
Niceforo, Alessia, et al. "Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency." Disease models & mechanisms vol. (2021). doi: https://doi.org/10.1242/dmm.046391
Niceforo A, Marioli C, Colasuonno F, Petrini S, Massey K, Tartaglia M, Bertini E, Moreno S, Compagnucci C. Altered cytoskeletal arrangement in induced pluripotent stem cells (iPSCs) and motor neurons from patients with riboflavin transporter deficiency. Dis Model Mech. 2021 Jan 19; doi: 10.1242/dmm.046391. Epub 2021 Jan 19. PMID: 33468503; PMCID: PMC7927654.
Copy Download .nbib Format: NLM
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER.

Clinical cancer research : an official journal of the American Association for Cancer Research

Petroni G, Buqué A, Yamazaki T, Bloy N, Liberto MD, Chen-Kiang S, Formenti SC, Galluzzi L.
PMID: 33495311
Clin Cancer Res. 2021 Apr 01;27(7):1855-1863. doi: 10.1158/1078-0432.CCR-20-3871. Epub 2021 Jan 25.

PURPOSE: Recent preclinical data suggest that cyclin-dependent kinase 4/6 (CDK4/6) inhibition may be harnessed to sensitize estrogen receptor-positive (EREXPERIMENTAL DESIGN: We combined radiotherapy and palbociclib in various doses and therapeutic schedules in human and mouse models of ERRESULTS: Radiotherapy...

Cite
Petroni G, Buqué A, Yamazaki T, et al. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER. Clin Cancer Res. 2021;27(7):1855-1863doi: 10.1158/1078-0432.CCR-20-3871.
Petroni, G., Buqué, A., Yamazaki, T., Bloy, N., Liberto, M. D., Chen-Kiang, S., Formenti, S. C., & Galluzzi, L. (2021). Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(7), 1855-1863. https://doi.org/10.1158/1078-0432.CCR-20-3871
Petroni, Giulia, et al. "Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,7 (2021): 1855-1863. doi: https://doi.org/10.1158/1078-0432.CCR-20-3871
Petroni G, Buqué A, Yamazaki T, Bloy N, Liberto MD, Chen-Kiang S, Formenti SC, Galluzzi L. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER. Clin Cancer Res. 2021 Apr 01;27(7):1855-1863. doi: 10.1158/1078-0432.CCR-20-3871. Epub 2021 Jan 25. PMID: 33495311; PMCID: PMC8327758.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 332 entries